dihexa safety concerns hgf c-met cancer risk Frontiers Dihexa (PNB-0408) | c-Met/HGFR Activator
Dihexa (PNB 0408) c Met HGFR Activator MedChemExpress Correlation between hypoxia and HGF c MET expression in the management of pancreatic cancer ScienceDirect Developing c MET pathway inhibitors for cancer therapy: progress and challenges: Trends in Molecular Medicine Frontiers The Function of the HGF c Met Axis in Hepatocellular Carcinoma
Pay in 4 interest-free payments of $6.96 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 17 - Sep 22



